Hogy Medical Co (3593) AI Stock Analysis

• Market Cap: ¥53.55B
• Dividend Yield: 2.49%
• Average Volume (3M): 82.01K
• Price to Earnings (P/E): 55.9
• Beta (1Y): 0.44
• Revenue Growth: 0.10%
• EPS Growth: -44.22%
• Country: JP
• Employees: 1,408
• Sector: Healthcare
• Sector Strength: 40
• Industry: Medical - Instruments & Supplies
• EPS (TTM): -52.92
• Shares Outstanding: 22,535,463
• 10 Day Avg. Volume: 63,000
• 30 Day Avg. Volume: 82,010
• PEG Ratio: -1.22
• Price to Book (P/B): 1.18
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 12.56
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: ¥3,697.82
• Price Target Upside: -2.56% Downside
• Rating Consensus: Hold
• Number of Analyst Covering: 0

• Rating: 63 Neutral
• Price Target: ¥4,237.00 ▲(11.65%Upside)

Hogy Medical Co's overall stock score is primarily supported by its strong financial stability and consistent cash flow generation, which account for a significant portion of its attractiveness. However, the high P/E ratio suggests overvaluation, limiting potential upside. Technical indicators provide a mixed view, contributing to a moderate overall score.

Hogy Medical Co Business Overview & Revenue Model

Company Description

Hogy Medical Co (3593) is a Japanese company specializing in the manufacturing and sale of medical and surgical supplies. The company focuses on providing a wide range of products including surgical gloves, surgical drapes, and custom procedure kits primarily to hospitals and healthcare institutions. Hogy Medical Co is recognized for its commitment to quality and innovation in the healthcare sector, enhancing operational efficiency and safety in medical settings.

How the Company Makes Money

Hogy Medical Co generates revenue through the sale of its medical and surgical products. The company's primary revenue streams include the production and distribution of surgical gloves, drapes, and procedure kits, which are essential components in surgical and medical procedures. Hogy Medical Co's revenue is driven by its ability to maintain strong relationships with hospitals and healthcare providers, ensuring a steady demand for its high-quality and reliable products. Additionally, the company may benefit from strategic partnerships and collaborations that enhance its market presence and access to new technologies, although specific details about such partnerships are not readily available.

Hogy Medical Co Financial Statement Overview

Summary

Hogy Medical Co demonstrates financial stability with a strong balance sheet and consistent cash flow generation. Despite some declines in profitability margins, the company maintains solid revenue and gross margin performance. Low leverage and a high equity ratio enhance its financial resilience.

Income Statement

Hogy Medical Co shows solid revenue stability with a slight increase in revenue over the years. The Gross Profit Margin is consistently strong, indicating effective cost management. However, there's a notable decline in Net Profit Margin and EBIT Margin in the latest year compared to prior periods, suggesting increased operational costs or lower pricing power. The EBITDA Margin remains robust, highlighting strong earnings before accounting for interest, taxes, depreciation, and amortization.

Balance Sheet

The company maintains a healthy balance sheet with a very low Debt-to-Equity Ratio, indicating low financial leverage. The Return on Equity has seen some fluctuation but remains positive, reflecting efficient use of equity capital. The Equity Ratio is high, signifying strong financing through equity and low reliance on debt, which provides financial stability.

Cash Flow

Hogy Medical Co exhibits strong cash flow with consistent Free Cash Flow generation and growth in Operating Cash Flow. The Free Cash Flow to Net Income Ratio indicates solid cash generation relative to net income, despite some variability in Free Cash Flow growth over the years. The Operating Cash Flow to Net Income Ratio showcases the company's ability to convert net income into cash effectively.

Breakdown	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Income Statement
Total Revenue	39.14B	39.10B	38.98B	36.78B	36.50B
Gross Profit	12.62B	12.49B	15.74B	15.42B	15.33B
EBITDA	8.75B	10.71B	10.25B	10.25B	10.18B
Net Income	1.52B	2.80B	4.32B	4.37B	4.96B
Balance Sheet
Total Assets	97.89B	100.04B	102.18B	98.97B	105.64B
Cash, Cash Equivalents and Short-Term Investments	22.00B	19.42B	18.86B	14.36B	20.55B
Total Debt	13.67B	5.82B	8.89B	10.00B	330.00M
Total Liabilities	23.56B	13.92B	18.50B	18.97B	9.69B
Stockholders Equity	74.32B	86.11B	83.61B	79.96B	95.88B
Cash Flow
Free Cash Flow	6.53B	4.32B	7.78B	5.30B	-686.00M
Operating Cash Flow	11.76B	7.12B	9.18B	8.50B	6.85B
Investing Cash Flow	-4.12B	-3.26B	-1.95B	-3.81B	-6.95B
Financing Cash Flow	-5.46B	-3.89B	-3.14B	-11.05B	-2.50B

Hogy Medical Co Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 3795.00
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:3593, the sentiment is Negative. The current price of 3795 is below the 20-day moving average (MA) of 3920.26, below the 50-day MA of 3909.33, and below the 200-day MA of 4446.77, indicating a bearish trend. The MACD of -26.42 indicates Positive momentum. The RSI at 40.98 is Neutral, neither overbought nor oversold. The STOCH value of 7.41 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:3593.

Hogy Medical Co Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
7817	77 Outperform	¥136.22B	15.85	6.55%	3.88%	2.42%	-13.12%
7716	75 Outperform	€167.12B	29.22	4.78%	2.66%	20.53%	-75.16%
7730	74 Outperform	¥118.86B	21.77		2.65%	5.82%	-20.09%
3593	63 Neutral	¥53.55B	55.85	1.87%	2.49%	0.10%	-44.22%
3154	62 Neutral	¥19.66B	14.57		2.15%	14.12%	56.92%
7702	58 Neutral	¥10.60B	119.45		3.92%	6.83%	―
Sector *	46 Neutral	C$201.03M	-3.36	-23.14%	2.62%	20.76%	-0.69%

Hogy Medical Co Corporate Events

Hogy Medical Co. Announces Shareholder Meeting Outcomes

Hogy Medical Co., Ltd. announced the results of its 64th Annual General Meeting of Shareholders, where the proposal for the election of directors was approved. Although one director candidate nominated by shareholders was elected, the company noted that this individual does not meet its criteria for independence. The newly elected director is expected to strengthen management oversight, contributing from a unique perspective compared to the current independent directors.

The most recent analyst rating on (JP:3593) stock is a Hold with a Yen3700.00 price target. To see the full list of analyst forecasts on Hogy Medical Co stock, see the JP:3593 Stock Forecast page.

Hogy Medical Announces Leadership Restructuring

Hogy Medical Co., Ltd. announced significant changes to its Board of Directors and executive officers, effective June 20, 2025, and July 1, 2025, respectively. These changes are expected to enhance the company’s leadership structure, potentially impacting its strategic direction and operational efficiency, which could have implications for stakeholders and the company’s market positioning.

The most recent analyst rating on (JP:3593) stock is a Hold with a Yen3700.00 price target. To see the full list of analyst forecasts on Hogy Medical Co stock, see the JP:3593 Stock Forecast page.

Hogy Medical’s Board Opposes Shareholder Proposal on Director Elections

Hogy Medical Co., Ltd.’s Board of Directors has decided to oppose a shareholder proposal from Nippon Active Value Fund plc regarding the election of three directors at the upcoming Annual General Meeting. The Board believes that its current composition, which includes a Nomination Committee to ensure independence and accountability, is optimal for implementing its medium-term management plan aimed at sustainable growth and enhanced corporate governance.

The most recent analyst rating on (JP:3593) stock is a Hold with a Yen3700.00 price target. To see the full list of analyst forecasts on Hogy Medical Co stock, see the JP:3593 Stock Forecast page.

Hogy Medical Co. Announces Leadership Changes to Strengthen Management

Hogy Medical Co., Ltd. announced a significant change in its leadership structure, with Taisuke Fujita being appointed as the new Representative Director and Vice President, effective June 20, 2025. This strategic move aims to strengthen the company’s management framework, potentially impacting its operational efficiency and market positioning. Additionally, the company will see the resignation of two outside directors, Kiyoshi Uesugi and Yuta Kinose, on the same date.

The most recent analyst rating on (JP:3593) stock is a Hold with a Yen3700.00 price target. To see the full list of analyst forecasts on Hogy Medical Co stock, see the JP:3593 Stock Forecast page.

Hogy Medical Co. Reports Decline in Profits Despite Stable Sales

Hogy Medical Co., Ltd. reported its consolidated financial results for the fiscal year ending March 31, 2025, showing a slight increase in net sales by 0.1% to ¥39,138 million. However, the company experienced a significant decline in profits, with operating profit down by 8.6% and profit attributable to owners of the parent down by 45.8%. Despite these challenges, the company maintained its dividend payments and forecasts a recovery in profits for the next fiscal year, indicating a strategic focus on improving financial performance.